LC-MS/MS determination of colistin in Mueller-Hinton broth for in vitro pharmacodynamic studies

Journal of Antibiotics

Volumn 67, Issue 12, 2014, Pages 825-829

  Zhao, Miao ^a   Cao, Yu Ran ^a   Guo, Bei Ning ^a   Wu, Xiao Jie ^a   Li, Jian ^b   Zhang, Jing ^a  

^a FUDAN UNIVERSITY   (China)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; COLISTIN A; COLISTIN B; POLYMYXIN B; UNCLASSIFIED DRUG; CULTURE MEDIUM;

ARTICLE; BACTERIAL GROWTH; BROTH DILUTION; CALIBRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; MUELLER HINTON BROTH; POSITIVE ION ELECTROSPRAY; PRIORITY JOURNAL; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; CHEMISTRY; CULTURE MEDIUM; DEVICES; HUMAN; PROCEDURES; REPRODUCIBILITY; STATISTICAL MODEL;

BACTERIA (MICROORGANISMS);

CHROMATOGRAPHY, LIQUID; COLISTIN; CULTURE MEDIA; HUMANS; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84925283555     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2014.73     Document Type: Article

References (18)

1. Bergen, P. J. et al. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? Diagn. Microbiol. Infect. Dis. 74, 213-223 (2012).
2. Orwa, J. A., Van Gerven, A., Roets, E. & Hoogmartens, J. Liquid chromatography of polymyxin B sulphate. J. Chromatogr. A 870, 237-243 (2000).
3. Bergen, P. J., Li, J., Rayner, C. R. & Nation, R. L. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50, 1953-1958 (2006).
4. Andes, D., Anon, J., Jacobs, M. R. & Craig, W. A. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections. Clin. Lab. Med. 24, 477-502 (2004).
5. Martinez, M. N., Papich, M. G. & Drusano, G. L. Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Antimicrob. Agents Chemother. 56, 2795-2805 (2012).
6. Velkov, T., Bergen, P. J., Lora-Tamayo, J., Landersdorfer, C. B. & Li, J. PK/PD models in antibacterial development. Curr. Opin. Microbiol. 16, 573-579 (2013).
7. Li, J.et al. Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography. Antimicrob. Agents Chemother. 46, 3304-3307 (2002).
8. Wan, E. C., Ho, C., Sin, D. W. & Wong, Y. C. Detection of residual bacitracin A, colistin A, and colistin B in milk and animal tissues by liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem. 385, 181-188 (2006).
9. Ma, Z., Wang, J., Gerber, J. P. & Milne, R. W. Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS. J. Chromatogr. B 862, 205-212 (2008).
10. Gobin, P., Lemaitre, F., Marchand, S., Couet, W. & Olivier, J. C. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry. Antimicrob. Agents Chemother. 54, 1941-1948 (2010).
11. Dotsikas, Y., Markopoulou, C. K., Koundourellis, J. E. & Loukas, Y. L. Validation of a novel LC-MS/MS method for the quantitation of colistin A and B in human plasma. J. Sep. Sci. 34, 37-45 (2011).
12. Xu, Y. et al. Analysis of colistin A and B in fishery products by ultra performance liquid chromatography with positive electrospray ionization tandem mass spectrometry. J. Chromatogr. B 899, 14-20 (2012).
13. Li, J. et al. A simple method for the assay of colistin in human plasma, using precolumn derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J. Chromatogr. B 761, 167-175 (2001).
14. Jansson, B., Karvanen, M., Cars, O., Plachouras, D. & Friberg, L. E. Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS. J. Pharm. Biomed. Anal. 49, 760-767 (2009).
15. Bergen, P. J. et al. Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. Antimicrob. Agents Chemother. 54, 3783-3789 (2010).
16. Plachouras, D. et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrob. Agents Chemother. 53, 3430-3436 (2009).
17. US Department of Health and Human Services. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation (US Department of Health and Human Services, 2013).
18. Liang, W. et al. Pharmacokinetics and pharmacodynamics of nemonoxacin against Streptococcus pneumoniae in an in vitro infection model. Antimicrob. Agents Chemother. 57, 2942-2947 (2013).